Chippenham SN15 2BB
44 12 4946 6966
Industry: Drug Manufacturers—Specialty & Generic
Full Time Employees: 285
|Mr. Andrew Timothy Franklin||Interim CEO, CFO & Exec. Director||417.2k||N/A||1966|
|Mr. Peter Jonathan Butterfield||CEO & Exec. Director (Leave of Absence)||978.91k||N/A||1976|
|Mr. Jeyan Heper (Hons), BA||COO & Director||N/A||N/A||N/A|
|Mr. Stephen Kidner||Chief Scientific Affairs Officer||N/A||N/A||N/A|
|Ms. Cora Maeve McCallum C.F.A.||Head of Investor Relations & Corp. Communications||N/A||N/A||N/A|
|Mr. Alex Duggan||Chief Commercial & Corp. Devel. Officer||N/A||N/A||N/A|
|Ms. Janice Timberlake||Chief People & Infrastructure Officer||N/A||N/A||N/A|
|Chris Delafield||Global Marketing Head of Kelo-Cote||N/A||N/A||N/A|
|Rhodri Smith||Head of Sourcing||N/A||N/A||N/A|
|Mr. Christodoulos Chrysanthou||Company Sec.||N/A||N/A||N/A|
Alliance Pharma plc operates as a pharmaceutical company in Europe, the Middle East, Africa, the Asia Pacific, China, and the Americas. The company acquires, markets, and distributes consumer healthcare and prescription medicine products. It holds the marketing rights of approximately 80 consumer healthcare and prescription medicine products. The company also offers medical devices, food supplements, and cosmetics. Alliance Pharma plc provides its products under the Aloclair, Anbesol, Asthon and Parsons, Atopiclair, Forceval, Hydromol, Kelo-cote, Macushield, Vamousse, Nizoral, and Amberen brand names. The company was founded in 1996 and is headquartered in Chippenham, the United Kingdom.
Alliance Pharma plc’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.